• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

释放T细胞代谢重编程的潜力:推进肿瘤免疫中精准免疫治疗的单细胞方法。

Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity.

作者信息

Huang Lihaoyun, Li Haitao, Zhang Cangang, Chen Quan, Liu Zaoqu, Zhang Jian, Luo Peng, Wei Ting

机构信息

Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

The First Clinical Medical School, Southern Medical University, Guangzhou, China.

出版信息

Clin Transl Med. 2024 Mar;14(3):e1620. doi: 10.1002/ctm2.1620.

DOI:10.1002/ctm2.1620
PMID:38468489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10928360/
Abstract

As single-cell RNA sequencing enables the detailed clustering of T-cell subpopulations and facilitates the analysis of T-cell metabolic states and metabolite dynamics, it has gained prominence as the preferred tool for understanding heterogeneous cellular metabolism. Furthermore, the synergistic or inhibitory effects of various metabolic pathways within T cells in the tumour microenvironment are coordinated, and increased activity of specific metabolic pathways generally corresponds to increased functional activity, leading to diverse T-cell behaviours related to the effects of tumour immune cells, which shows the potential of tumour-specific T cells to induce persistent immune responses. A holistic understanding of how metabolic heterogeneity governs the immune function of specific T-cell subsets is key to obtaining field-level insights into immunometabolism. Therefore, exploring the mechanisms underlying the interplay between T-cell metabolism and immune functions will pave the way for precise immunotherapy approaches in the future, which will empower us to explore new methods for combating tumours with enhanced efficacy.

摘要

由于单细胞RNA测序能够对T细胞亚群进行详细聚类,并有助于分析T细胞代谢状态和代谢物动态变化,它已成为理解异质性细胞代谢的首选工具而备受瞩目。此外,肿瘤微环境中T细胞内各种代谢途径的协同或抑制作用是相互协调的,特定代谢途径活性的增加通常对应着功能活性的增强,从而导致与肿瘤免疫细胞效应相关的多种T细胞行为,这显示了肿瘤特异性T细胞诱导持久免疫反应的潜力。全面了解代谢异质性如何调控特定T细胞亚群的免疫功能,是在免疫代谢领域获得深入见解的关键。因此,探索T细胞代谢与免疫功能之间相互作用的潜在机制,将为未来精确免疫治疗方法铺平道路,使我们能够探索更有效的对抗肿瘤的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/c462bf35a4ca/CTM2-14-e1620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/0549850f85fb/CTM2-14-e1620-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/282c09167238/CTM2-14-e1620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/668b0a5142dc/CTM2-14-e1620-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/add98b28b354/CTM2-14-e1620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/c462bf35a4ca/CTM2-14-e1620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/0549850f85fb/CTM2-14-e1620-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/282c09167238/CTM2-14-e1620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/668b0a5142dc/CTM2-14-e1620-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/add98b28b354/CTM2-14-e1620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397e/10928360/c462bf35a4ca/CTM2-14-e1620-g001.jpg

相似文献

1
Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity.释放T细胞代谢重编程的潜力:推进肿瘤免疫中精准免疫治疗的单细胞方法。
Clin Transl Med. 2024 Mar;14(3):e1620. doi: 10.1002/ctm2.1620.
2
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.利用代谢重编程来改善癌症免疫疗法。
Int J Mol Sci. 2021 Sep 24;22(19):10268. doi: 10.3390/ijms221910268.
3
Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity.肿瘤免疫中 T 细胞的糖代谢:障碍还是推进器?
Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189022. doi: 10.1016/j.bbcan.2023.189022. Epub 2023 Nov 20.
4
Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment.肿瘤微环境中巨噬细胞和 T 细胞代谢重编程及免疫治疗的研究进展
PeerJ. 2024 Jan 15;12:e16825. doi: 10.7717/peerj.16825. eCollection 2024.
5
Advances in reprogramming of energy metabolism in tumor T cells.肿瘤 T 细胞能量代谢重编程的研究进展。
Front Immunol. 2024 Feb 13;15:1347181. doi: 10.3389/fimmu.2024.1347181. eCollection 2024.
6
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.肿瘤免疫治疗中T细胞寿命和功能的代谢调控
Cell Metab. 2017 Jul 5;26(1):94-109. doi: 10.1016/j.cmet.2017.06.016.
7
Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy.针对 PPAR 配体作为癌症免疫治疗中 T 细胞代谢重编程的可能方法。
Immunol Lett. 2020 Apr;220:32-37. doi: 10.1016/j.imlet.2020.01.006. Epub 2020 Jan 23.
8
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.探索代谢途径以增强抗肿瘤免疫和免疫治疗。
Nat Rev Clin Oncol. 2019 Jul;16(7):425-441. doi: 10.1038/s41571-019-0203-7.
9
New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.基于肿瘤免疫微环境中细胞类型特异性代谢重编程的新型免疫代谢策略。
Cells. 2022 Feb 22;11(5):768. doi: 10.3390/cells11050768.
10
Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.二甲双胍的免疫介导抗肿瘤作用;靶向 T 细胞的代谢重编程作为二甲双胍抗肿瘤作用的新可能机制。
Biochem Pharmacol. 2020 Apr;174:113787. doi: 10.1016/j.bcp.2019.113787. Epub 2019 Dec 27.

引用本文的文献

1
Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.解码肿瘤微环境中的代谢对话:从免疫抑制到精准癌症治疗
Exp Hematol Oncol. 2025 Jul 22;14(1):99. doi: 10.1186/s40164-025-00689-6.
2
Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy.纳米医学驱动的肿瘤葡萄糖代谢重编程以增强癌症免疫治疗
Acta Pharm Sin B. 2025 Jun;15(6):2845-2866. doi: 10.1016/j.apsb.2025.04.002. Epub 2025 Apr 4.
3
CD28 and ICOS in immune regulation: Structural insights and therapeutic targeting.

本文引用的文献

1
Targeting the metabolism of tumor-infiltrating regulatory T cells.靶向肿瘤浸润调节性 T 细胞的代谢。
Trends Immunol. 2023 Aug;44(8):598-612. doi: 10.1016/j.it.2023.06.001. Epub 2023 Jul 11.
2
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.单细胞RNA测序和批量RNA测序的综合分析揭示了三阴性乳腺癌中与T细胞相关的预后风险模型及肿瘤免疫微环境调节。
Comput Biol Med. 2023 Jul;161:107066. doi: 10.1016/j.compbiomed.2023.107066. Epub 2023 May 27.
3
Polyamine metabolism patterns characterized tumor microenvironment, prognosis, and response to immunotherapy in colorectal cancer.
CD28和ICOS在免疫调节中的作用:结构见解与治疗靶点
Bioorg Med Chem Lett. 2025 Jun 15;127:130310. doi: 10.1016/j.bmcl.2025.130310.
4
Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment.营养基因疗法作为一种增强嵌合抗原受体T细胞(CAR T细胞)功能并克服肿瘤微环境中障碍的策略。
J Transl Med. 2025 Jun 6;23(1):633. doi: 10.1186/s12967-025-06606-z.
5
Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment.自然杀伤细胞免疫检查点及其在癌症治疗中的靶向治疗
Research (Wash D C). 2025 Jun 3;8:0723. doi: 10.34133/research.0723. eCollection 2025.
6
Integrated Single-Cell and Spatial Transcriptome Reveal Metabolic Gene SLC16A3 as a Key Regulator of Immune Suppression in Hepatocellular Carcinoma.整合单细胞和空间转录组揭示代谢基因SLC16A3是肝细胞癌免疫抑制的关键调节因子。
J Cell Mol Med. 2024 Dec;28(23):e70272. doi: 10.1111/jcmm.70272.
7
Metabolic Reprogramming of CD4 T Cells by Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuates Autoimmune Hepatitis Through Mitochondrial Protein Transfer.间充质干细胞衍生的细胞外囊泡对 CD4 T 细胞的代谢重编程通过线粒体蛋白转移减轻自身免疫性肝炎。
Int J Nanomedicine. 2024 Sep 23;19:9799-9819. doi: 10.2147/IJN.S472086. eCollection 2024.
8
Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event.Lck的功能与调节:免疫细胞毒性反应及肿瘤治疗——远非简单事件
Cancers (Basel). 2024 Jul 24;16(15):2630. doi: 10.3390/cancers16152630.
9
Emerging mechanisms and promising approaches in pancreatic cancer metabolism.胰腺癌代谢中的新兴机制与前景广阔的方法
Cell Death Dis. 2024 Aug 1;15(8):553. doi: 10.1038/s41419-024-06930-0.
多胺代谢模式可表征结直肠癌的肿瘤微环境、预后及对免疫治疗的反应。
Cancer Cell Int. 2023 May 18;23(1):96. doi: 10.1186/s12935-023-02892-z.
4
Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma.硒代谢调节剂相关预后模型在肝细胞癌中的建立和验证。
BMC Cancer. 2023 May 18;23(1):451. doi: 10.1186/s12885-023-10944-w.
5
Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer.二甲双胍重编程色氨酸代谢以刺激结直肠癌中的 CD8+T 细胞功能。
Cancer Res. 2023 Jul 14;83(14):2358-2371. doi: 10.1158/0008-5472.CAN-22-3042.
6
Immunosenescence: molecular mechanisms and diseases.免疫衰老:分子机制与疾病。
Signal Transduct Target Ther. 2023 May 13;8(1):200. doi: 10.1038/s41392-023-01451-2.
7
Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression.糖异生酶 PCK1 支持 S- 腺苷甲硫氨酸的生物合成,并促进 H3K9me3 的修饰,以抑制肝癌的进展。
J Clin Invest. 2023 Jul 3;133(13):e161713. doi: 10.1172/JCI161713.
8
Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells.癌细胞对蛋氨酸的消耗导致 CD4 T 细胞中 PD-1 表达的逐渐上调。
Nat Commun. 2023 May 5;14(1):2593. doi: 10.1038/s41467-023-38316-9.
9
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.二甲双胍通过直接挽救缺氧诱导的免疫抑制肿瘤浸润 CD8 T 淋巴细胞来改善癌症免疫治疗。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-005719.
10
Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma.肿瘤分泌的乳酸有助于形成免疫抑制微环境,并影响胶质母细胞瘤中 CD8 T 细胞的浸润。
Front Immunol. 2023 Apr 12;14:894853. doi: 10.3389/fimmu.2023.894853. eCollection 2023.